✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Medicamen Organics Ltd.

MEDIORG

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹51 Cr.
P/E
15.56

Medicamen Organics Ltd.

  • Medicamen Organics
  • Lasa Supergenerics
  • Kabra Drugs
FAQs on Medicamen Organics Ltd. Shareprice

Medicamen Organics has given lower returns compared to its competitors.
Medicamen Organics has grown at ~-43.58% over the last 1yrs while peers have grown at a median rate of -20.0%

Medicamen Organics is not expensive.
Latest PE of Medicamen Organics is 15.56, while 3 year average PE is 24.32.
Also latest EV/EBITDA of Medicamen Organics is 5.33 while 3yr average is 10.16.

View FAQ's On Business
Growth Table
  • Medicamen Organics Ltd.
  • Lasa Supergenerics
  • Kabra Drugs
Balance Sheet
  • Medicamen Organics Ltd.
  • Lasa Supergenerics
  • Kabra Drugs
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Medicamen Organics Ltd.
  • Lasa Supergenerics
  • Kabra Drugs
Cash Flow
  • Medicamen Organics Ltd.
  • Lasa Supergenerics
  • Kabra Drugs
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Medicamen Organics Ltd.
  • Lasa Supergenerics
  • Kabra Drugs
Quarterly Results
  • Medicamen Organics Ltd.
  • Lasa Supergenerics
  • Kabra Drugs
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Medicamen Organics Ltd. Financials

Balance sheet of Medicamen Organics is moderately strong, But short term working capital might become an issue for this company.

The net debt of Medicamen Organics is decreasing.
Latest net debt of Medicamen Organics is ₹8.22 Crs as of Mar-25.
This is less than Mar-24 when it was ₹11.96 Crs.

Yes, profit is increasing.
The profit of Medicamen Organics is ₹3.27 Crs for TTM, ₹2.4 Crs for Mar 2024 and ₹0.97 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Medicamen Organics latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech